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Abstract
Background and Objectives: In Brazil, as in many other affected countries, a large proportion of visceral leishmaniasis (VL)
occurs in remote locations and treatment is often performed on basis of clinical suspicion. This study aimed at developing
predictive models to help with the clinical management of VL in patients with suggestive clinical of disease.
Methods: Cases of VL (n=213) had the diagnosis confirmed by parasitological method, non-cases (n=119) presented
suggestive clinical presentation of VL but a negative parasitological diagnosis and a firm diagnosis of another disease. The
original data set was divided into two samples for generation and validation of the prediction models. Prediction models
based on clinical signs and symptoms, results of laboratory exams and results of five different serological tests, were
developed by means of logistic regression and classification and regression trees (CART). From these models, clinical-
laboratory and diagnostic prediction scores were generated. The area under the receiver operator characteristic curve,
sensitivity, specificity, and positive predictive value were used to evaluate the models’ performance.
Results: Based on the variables splenomegaly, presence of cough and leukopenia and on the results of five serological tests
it was possible to generate six predictive models using logistic regression, showing sensitivity ranging from 90.1 to 99.0%
and specificity ranging from 53.0 to 97.2%. Based on the variables splenomegaly, leukopenia, cough, age and weight loss
and on the results of five serological tests six predictive models were generated using CART with sensitivity ranging from
90.1 to 97.2% and specificity ranging from 68.4 to 97.4%. The models composed of clinical-laboratory variables and the rk39
rapid test showed the best performance.
Conclusion: The predictive models showed to be a potential useful tool to assist healthcare systems and control programs
in their strategical choices, contributing to more efficient and more rational allocation of healthcare resources.
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Introduction
Visceral leishmaniasis (VL) is a neglected tropical disease caused
by the intracellular protozoan parasite Leishmania infantum (syn.
Leishmania chagasi). The disease is endemic to 65 countries and 90%
of world cases are reported in India, Bangladesh, Nepal, Ethiopia,
Brazil, and the Sudan [1]. In Brazil, more then 15.000 VL cases
were reported between 2007 and 2010, with 880 deaths [2]. The
disease primarily affects the poorest people and is fatal if
untreated. The control strategies used in Brazil to reduce the
disease morbidity and mortality rates consists on the early
diagnosis and treatment of human cases and the control of the
populations of domestic reservoirs and vectors [3].
Early diagnosis is a challenge in Brazil, as in other affected
countries, where the disease is still frequently treated only on the
basis of clinical suspicion. Clinically, the disease is characterized by
prolonged fever, substantial weight loss, hepatomegaly, spleno-
megaly, pancytopenia, hypergammaglobulinemia [3,4]. The firm
diagnosis of VL needs to rely on efficacious laboratorial support.
The current reference test for disease diagnostic is the microscopic
demonstration of Leishmania in spleen, bone marrow, lymph nodes
or liver aspirates, but both the aspiration procedure and the
reading of slides require a high level of expertise that makes them
unsuitable for generalized field use [1,3].
Several serological diagnostic methods have been widely
evaluated for the diagnosis of VL, such as the enzyme linked
immunosorbent assay (ELISA) with different antigens and the
indirect fluorescence antibody test (IFAT). In Brazil, IFAT is the
serologic test made available by the Public Health System. ELISAs
and IFAT depend on equipment and laboratorial infrastructure.
Two other tests easy to use have been appointed as appropriate for
the diagnosis of VL in control programs: the Direct Agglutination
Test (DAT) and the rK39 rapid tests [5–8].
The development of predictive models could help in the
management of patients, especially in towns where the access to
diagnostic methods is difficult, being useful as a cost-effective tool
in a health care system with limited resources. This study aimed
at developing models based on scoring systems using logistic
www.plosntds.org 1 February 2012 | Volume 6 | Issue 2 | e1542regression and classification and regression trees (CART) to
predict the occurrence of VL in patients with suggestive clinical of
disease in Brazil.
Methods
Settings and patient selection
The models were developed using a database generated from a
prospective study conducted in four states of Brasil, published
elsewhere [7,9]. We evaluated a group of 332 patients with
symptoms and/or signs suggestive of VL referred for diagnostic
and eventual treatment in states of Maranha ˜o (Federal University
of Maranha ˜o, 35 patients enrolled), Piauı ´ (Federal University of
Piauı ´, 121 patients), Bahia (Gonc ¸alo Muniz Research Center, 119
patients) and Minas Gerais (Rene ´ Rachou Research Center, 57
patients), from May 2005 and May 2007.
By the end of clinical investigation, all VL cases had the
diagnosis confirmed by parasitological methods. The non-cases
had suggestive clinical presentation of VL, a negative parasitolog-
ical diagnosis and the accomplished diagnosis of another disease.
The non-cases were diagnosed with various diseases, such as
leukemia, liver disease, schistosomiasis, ascariasis, liver fibrosis,
lymphoma, rheumatoid arthritis, malaria, mononucleosis, typhoid
fever, marrow aplasia, liver cirrhosis, meningitis, lupus erythema-
tosus, encephalitis, tuberculosis, among others.
Procedures and diagnostic tests
Patients underwent a standardized interview regarding epide-
miological and clinical history and a physical examination. IFAT
was performed with an industrial kit (Biomanguinhos, Rio de
Janeiro, Brazil) according to the manufacturer’s instructions.
Samples scored positive when fluorescent microscopy showed clear
evidence that they produced a cytoplasmic or membranous
fluorescence with promastigotes using a cut-off dilution of 1:80.
L. chagasi-ELISA and rK39-ELISA were performed according to
Assis et al. (2008) [9]. The cutoff of reactions was determined as
the mean plus two standard deviations of the absorbance of
control sera (n=20). DAT was performed according to Pedras
et al. (2008) [10]. The cutoff value was determined by analyzing
the receiver operator characteristic curve. Rapid test (IT-LEISHH
Diamed Latino-America S. A. - Cressier sur Morat, Switzerland)
was performed according to the manufacturer’s instructions and
Assis et al. (2008) [9]. The test was positive when two red lines
appeared in the middle of the nitrocellulose membrane, negative
when only one redline appeared and invalid when no line was
evident. The rapid test and the bone marrow aspirate were
performed at the center of origin of the patients evaluated; all
other serological tests were performed at the Rene Rachou
Research Center.
Ethical issues
The Research Ethics Committee of Rene ´ Rachou Research
Center and all other institutions involved in this study had
previously approved the informed consent forms and procedures.
Written informed consent was obtained from all the adults and
from minors’ parents or legal guardians. The study was conducted
in agreement with the principles of the Helsinki Declaration and
the Resolution 196/96 of the National Health Council of the
Ministry of Health that regulates research involving human
subjects in Brazil (CEPSH/CPqRRnu: 13/2003).
Statistical analysis
The original data set was randomly divided into 2 parts: the
‘‘test sample’’ (patients from Maranha ˜o, Piauı ´ and Minas Gerais,
n=213) was used to construct the models and the ‘‘validation
sample’’ (patients from Bahia, n=119) was used to validate the
models. Predictive models were built using logistic regression and
CART. Statistical analyses were performed using Stata, version
10.0 (Stata), and Splus, version 4.5 (StatSci).
For developing predictive models with logistic regression,
initially the most important factors associated with the occurrence
of visceral leishmaniasis were identified. A p-value of #0.2 for
the univariate association with visceral leishmaniasis was used for
selecting variables for the multivariate model. A stepwise eli-
mination procedure was performed, using a p-value de #0.05 as
the criterion for variables to remain in the model.
A predictive model based on a scoring system, with points
allocated to each prognostic factor, was created from the final
logistic regression model run in the test sample. The scoring system
was generated by dividing the value of the regression coefficient of
each variable by the smallest coefficient and rounding the quotients
to the closest integer [11]. Posteriorly, the final score was obtained
through the sum of points attributed to the presence of each
predictive variable that remained in the final model and to the
results of five diagnostic methods: IFAT, L. chagasi-ELISA, rK39-
ELISA, DAT and rapid test.
For constructing predictive model using CART all available
variables were initially included in the analysis. The CART
method was used to build a binary classification tree through
successive partitions, dividing the data into more homogeneous
subgroups at each split (‘‘node’’). At each node, the algorithm
selected the variable with the greatest capacity for discriminating
between the 2 outcome groups (VL and non-VL). The first
division of the tree corresponds to the variable with the greatest
ability to discriminate between VL cases and non-VL patients; the
discriminatory power decreases with each subsequent division
(‘‘branch’’).
The CART algorithm adds nodes until they are homogenous or
contains few observations. The problem of creating a useful tree is
to find suitable guidelines to achieve a tree with a lower level of
misclassification but, at the same time, not too much adjusted to
the data. This can be accomplished by downsizing (‘‘pruning’’) the
tree. The general principle of pruning is that the tree of best size
Author Summary
Visceral leishmaniasis (VL) is a neglected tropical disease
endemic to 65 countries, including Brazil, where the
disease frequently occurs in remote locations and treat-
ment is often performed on the basis of clinical suspicion.
Predictive models based on scoring systems could be a
helpful tool for the clinical management of VL. Based on
clinical signs and symptoms, and five different serological
tests of 213 patients with parasitologically confirmed
(cases) and 119 with clinical suspicion of VL but with
another confirmed etiology (non-cases), twelve prediction
models using logistic regression and classification and
regression trees (CART) for VL diagnosis were developed.
The model composed of the clinical-laboratory variables
and the rk39 rapid test showed the best performance in
both logistic regression and CART (Sensitivity of 90.1% and
specificity ranging from 97.2–97.4%). The scoring system is
simple and based on the clinical-laboratory findings that
are easily available in most clinical settings. The results
suggest that those models might be useful in locations
where access to available diagnostic methods is difficult,
contributing to more efficient and more rational allocation
of healthcare resources.
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included in the original data [12]. Pruning was achieved by
decreasing the number of nodes without a significant increase of
deviance, with the aid of a graph that shows the relationship
between deviance and the number of nodes on the tree [13]. The
best tree suggested by our analysis had 7 leaves.
The sensitivity, specificity, positive predictive value (PPV) and
area under the receiver operator characteristic (ROC) curve were
used to evaluate the performance of the models. The sensitivity is
the probability of the test result be positive among patients with
the disease, specificity is the probability of the test result be
negative among patients without the disease and PPV is the
probability that a patient has the disease given a positive test result.
The ROC curve consists of a graph of sensitivity versus false
positive rate and the area under this curve provides a summary of
the ability of a test to discriminate two groups (here, VL and non-
VL patients).
Results
Three hundred thirty-two patients were included in the analysis,
213 parasitologically confirmed VL cases and 119 non-cases with
clinical suspicion of VL but with another confirmed etiology.
Detailed description of the group and validation of the rK39 rapid
test and DAT is reported by Assis et al. (2011) [7]. The average
age of the VL cases in test sample was 21 years (1 month to 74
years), and 63% (n=88) were female and the average age of the
non-cases was 16 years (2 months to 66 years), and 60% (n=44)
were female. Table 1 shows the clinical and laboratory cha-
racteristics of subjects in the test sample. Table 2 shows the
predictive variables that remained in the final logistic regression
model: Splenomegaly, leukopenia and cough. The score system
generated by using logistic regression attributed 21 point for
cough, 1 point for leukopenia, 3 points for splenomegaly and
positive IFAT, 4 points for positive L. chagasi ELISA, 5 points for
positive rK39 rapid test, 6 points for positive rK39-ELISA and 7
points for positive DAT (Table 3).
The CART model was composed by the variables splenomeg-
aly, leukopenia, cough, age and weight loss (Figure 1). The
variable with the greatest discriminative power was splenomegaly.
The probabilities of VL, as predicted in the leaves of the tree,
ranged from 0% to 87%.
Table 3 and 4 show the comparison of the predictive
performance of different models generated using logistic regression
and CART in terms of the area under the ROC curve, sensitivity,
specificity, and PPV evaluated in both test and validation samples.
Using logistic regression it was possible to generate predictive
models for the diagnostic of VL with sensitivity ranging from 90.1
to 99.0% and specificity ranging from 53.0 to 97.2%. Using
CART it was possible to generate predictive models for VL with
sensitivity ranging from 90.1 to 97.2% and specificity ranging from
68.4 to 97.4%. Logistic regression and CART in the test sample
and validation sample had similar performance for most models.
Figure 2 presents one example, based in models developed using
logistic regression, on how a chart could be used to help health
professionals with the tests interpretation and the physicians with
the clinical decision. In the validation sample, in the first model,
composed only by clinical-laboratory variables, patients with score
$3 (82/107–51%) showed a probability of having VL of 79%
(data not shown). In the second model, when IFAT was added,
patients with score $4 (78/107–73%) had a probability of VL of
90%. In the third model, which included clinical and laboratorial
features and L. chagasi ELISA, patients with a score $5 (68/107–
63%) had 94.1% probability of VL. In the model combining
clinical-laboratory variables plus rK39 ELISA, patients with score
$7 (72/107–67%) presented 94.4% VL probability. In the fifth
model, adding DAT to clinical and laboratorial findings, patients
with score $5 (68/107–63%) showed also a 94% probability of a
VL diagnostic. Still, in the sixth model (clinical-laboratory plus
rK39 rapid test) patients with score $5 (65/107–61%) showed the
higher VL probability (PPV 98.5%).
Discussion
VL is a serious disease, with repeatedly recognition of the lack of
sufficient means for its elimination. Rapid diagnostic and adequate
treatment of cases would certainly help to reduce morbidity and
mortality and it may contribute also to decrease transmission
where anthroponotic VL transmission occurs. Clinical diagnosis of
VL is inaccurate because it’s clinical presentation shares common
features to several other diseases and can vary in different endemic
areas. In the present study, splenomegaly, leukopenia and cough
were the clinical-laboratory variables that remained in the
predictive model using logistic regression; and splenomegaly,
leukopenia, cough, age and weight loss were the clinical-laboratory
variables that remained in the predictive model using CART for
VL diagnosis.
Splenomegaly is a classic sign of VL that with the advance of
disease can cause abdominal distension and pain. In the study by
Tanoli et al. (2005) [14] in Pakistan, 95% of patients had
splenomegaly and in the study by Daher et al. (2008) [15] and
Rocha et al. (2011) [16] in Brazil, 96% and 94% of the patients,
respectively, showed this signal, as well. Leukopenia and weigh loss
are reported frequently in clinical studies involving patients with
VL. In the study by Dursun et al. (2009) [17] in Turkey, 74% of
the patients had leukopenia, and in the study by Queiroz et al.
(2004) [18] and Daher et al. (2008) [15] in Brazil, 85% of the
patients showed leukopenia and 95% showed weigh loss,
respectively. Several authors have reported that the VL is
predominant in children early in life and is associated with high
morbidity and high number of deaths [17–18]. Other manifesta-
tions can be seen less consistent with the LV, such as cough and
diarrhea [16,18]. In this study cough was a sign negatively
correlated to LV. Therefore, VL should be suspected in endemic
areas when patients present enlarged spleen, leukopenia and weigh
loss, especially in children early in life.
Laboratory diagnosis of VL is, still now, complex. The
sensitivity of parasitological tests is suboptimal, ranging from 53–
86% for bone marrow up to 93–99% for spleen aspirates [1].
Diagnostic research in VL has been damaged by the lack of a
perfect gold standard. An alternative to the classical validation
approach using parasitological diagnostic methods as the gold
standard is the latent class analysis (LCA). LCA is based on the
concept that the observed results of different imperfect tests for the
same disease are influenced by a latent common variable, the true
disease status, which cannot be directly measured [19–21]. Several
studies used LCA methodology for the evaluation of diagnostic
tests for VL, such as Boelaert et al. (1999, 2004 and 2008) [22–24],
Horst et al. (2009) [25] and Menten et al. (2008) [26].
Less invasive methods are being evaluated for VL diagnosis.
IFAT, ELISA, and a polymerase chain reaction are examples of
these efforts. Unfortunately, all of these tests require laboratory
infrastructure and specialized professionals. More recently,
alternatives to the methods mentioned above, such as DAT and
rapid test have become available. DAT and rK39 show high
sensitivity, specificity, rapid results and are easy to use [5–7]. In the
multicenter study performed in Brazil, which served as the basis
for the development of the predictive models presented, the IFAT
Predictive Models for Visceral Leishmaniasis
www.plosntds.org 3 February 2012 | Volume 6 | Issue 2 | e1542showed sensitivity of 88% and specificity of 81%, the L. chagasi
ELISA showed sensitivity of 92% and specificity of 77%, the
rK39-ELISA showed sensitivity of 97% and specificity of 84% [9],
the rapid test IT-LEISHH showed sensitivity of 93% and specificity
of 97% and the DAT showed sensitivity of 90% and a specificity of
96% [7].
In the present study, it was possible to generate predictive
models for VL with good general predictive performance. It was
observed that the generated models showed better performance
compared to the model based only on clinical-laboratory variables,
reinforcing the importance of diagnostic tests in patients’
management. From the standpoint of performance and practical-
ity, the sixth model, composed of clinical-laboratory variables and
the rK39 rapid test, developed using both logistic regression and
CART, may represent the best suitability for use in peripheral
services and referral centers, since the rapid test is easy to perform
and to interpret, with result available within 20 minutes. Other
models, such as the second, composed of clinical-laboratory
Table 1. Clinical and laboratory characteristics of VL and non-VL cases, among 213 patients with clinical suspicion of VL in test sample.
Clinical and laboratory
characteristics VL cases Non- LV cases OR 95% CI p value
N% N%
Age (years) Continuous 0.9 0.96–0.99 0.001
Sex
Female 88 62.9 44 60.3 1.0
Male 52 37.1 29 39.7 0.9 0.50–1.60 0.70
Weight loss
Yes 115 87.8 51 78.5 2.0 0.90–4.34 0.09
No 16 12.2 14 21.5 1.0
Cough
Yes 48 35.6 35 52.2 0.5 0.28–0.91 0.02
No 87 64.4 32 47.8 1.0
Diarrhea
Yes 34 25.4 19 28.4 0.9 0.44–1.70 0.6
No 100 74.6 48 71.6 1.0
Jaundice
Yes 19 14.3 21 30.4 0.4 0.19–0.77 0.01
No 114 85.7 48 69.6 1.0
Bleeding
Yes 13 9.8 15 22.7 0.4 0.16–0.83 0.02
No 120 90.2 51 77.3 1.0 - -
Splenomegaly
Yes 127 90.7 36 49.3 10.0 4.83–21.0 ,0.001
No 13 9.3 37 50.7 1.0 - -
Hepatomegaly
Yes 95 67.9 32 43.8 2.7 1.51–4.84 0.001
No 45 32.1 41 56.2 1.0 - -
Leukopenia
Yes 99 74.4 30 42.3 4.0 2.16–7.33 ,0.001
No 34 25.6 41 57.7 1.0 - -
Plaquetopeny
Yes 81 72.3 34 50.8 2.5 1.35–4.78 0.004
No 31 27.7 33 49.2 1.0 - -
doi:10.1371/journal.pntd.0001542.t001
Table 2. Variables significantly associated with visceral leishma-
niasis in multiple logistic regression, clinical-laboratory (final model).
Variable OR 95% CI p value
Splenomegaly
Yes 17.0 6.0–47.4 0.00
No 1.00
Leukopenia
Yes 4.5 2.0–10.4 0.00
No 1.00
Cough
Yes 0.37 0.16–0.84 0.02
No 1.00
doi:10.1371/journal.pntd.0001542.t002
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Curve (%) (95% CI)
Positive predictive
value (%) (95% CI)
1. Clinical-laboratory* (21/4) $3 81.4 (74.0–88.0) 65.2 (52.4–76.5) 79.4 (72.0–87.0) 82.0 (74.3–88.3)
2. Clinical-laboratory* 91.5 (82.5–97.0) 53.0 (35.5–70.0) 74.0 (61.3–86.3) 79.3 (69.0–87.4)
1. Clinical-laboratory*+L. chagasi-ELISA (21/8) $5 91.5 (85.3–96.0) 80.3 (69.0–89.1) 93.1 (89.5–97.0) 90.1 (84.0–95.0)
2. Clinical-laboratory*+L. chagasi-ELISA 90.1 (81.0–96.0) 89.0 (74.0–97.0) 91.0 (85.0–97.3) 94.1 (86.0–98.4)
1. Clinical-laboratory*+IFAT (21/7) $4 90.0 (83.4–94.5) 77.3 (65.3–87.0) 90.4 (86.0–95.0) 88.5 (82.0–93.4)
2. Clinical-laboratory*+IFAT 99.0 (92.4–100) 78.0 (61.0–90.0) 95.0 (89.0–100) 90.0 (81.0–95.5)
1. Clinical-laboratory*+rK39-ELISA (21/10) $7 98.0 (93.4–99.5) 88.0 (77.5–95.0) 97.0 (94.1–100) 94.0 (89.0–97.4)
2. Clinical-laboratory*+rK39-ELISA 96.0 (88.1–99.1) 89.0 (74.0–97.0) 93.4 (87.0–100) 94.4 (86.4–98.5)
1. Clinical-laboratory*+DAT (21/11) $5 90.0 (83.4–94.5) 97.0 (89.5–100) 97.3 (95.4–99.2) 98.3 (94.0–100)
2. Clinical-laboratory*+DAT 91.5 (82.5–97.0) 92.0 (77.5–98.2) 97.0 (88.0–99.1) 94.0 (87.3–100)
1. Clinical-laboratory*+rK39 rapid test (21/9) $5 94.0 (88.1–97.3) 95.5 (87.3–99.1) 98.5 (97.2–100) 98.0 (93.1–99.5)
2. Clinical-laboratory*+rK39 rapid test 90.1 (81.0–96.0) 97.2 (85.5–100) 95.5 (91.4–99.4) 98.5 (92.0–100)
1 Test sample; 2 Validation sample;
*The model Clinical-laboratory was composed by variables: Splenomegaly and Leukopenia. Points assigned to variables in the models: Cough=21, leukopenia=1,
splenomegaly and IFAT=3, L. chagasi-ELISA=4, rK39 rapid test=5, rK39-ELISA=6 and DAT=7.
doi:10.1371/journal.pntd.0001542.t003
Figure 1. Classification and regression tree for predicting visceral leishmaniasis in patients with suggestive clinical. Classification and
regression tree model for predicting VL. The number of patients (N) and the probability of VL (% with VL) are shown at each node. Terminal nodes are
shaded.
doi:10.1371/journal.pntd.0001542.g001
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technique already implemented.
Clinical prediction models have been developed to help
physicians improve the assessment of an individual’s risk of a
disease or to predict an outcome, for a great number of diseases,
such as tuberculosis and pneumonia. It is the first time that this
type of predictive model is developed for human VL and it
represents an innovative approach in disease diagnosis. It was out
of the scope of this study to evaluate the interference of epidemics
or the seasonality of the disease and the possible use of other
models as the early warning systems (EWS) based on environ-
mental variables that have been developed to predict the
occurrence of epidemics of cutaneous leishmaniasis and could be
also applied to VL [27].
The use of a control group (non-VL patients) with a variety of
diseases that can mimic VL and representative of the population
that seeks references centers for VL in Brazil is one of the strong
features of this study, providing a realistic scenario for the use of
the predictive models generated. However, there are also some
methodological limitations in our study that should be considered
before deciding to apply the results of models in clinical practice.
First, although our modeling strategy used geographically different
samples for deriving and validating the models, one need to be
cautious about the possibility that the patients enrolled in our
study may not be representative of populations from other settings.
Second, the patients were already identified at admission to be at
risk for VL, in this sense our models were developed for a
population attending to referral centers and might not be useful in
different circumstances. Third, the small size of the validation
sample, as compared to sample derivation contributed to the
relatively low precision of sensitivity, specificity, PPV and the area
under the receiver operator characteristic estimates in the
Table 4. Predictive performance of different models in classification and regression trees (CART).
Models Sensitivity (%) (95% CI) Specificity (%) (95% CI)
Area under ROC
Curve (%) (95% CI)
Positive predictive
value (%) (95% CI)
1. CART* 80.4 (73.0–87.0) 75.4 (63.5–85.0) 84.0 (76.2–91.3) 86.3 (79.0–92.0)
2. CART* 90.1 (81.0–96.0) 68.4 (51.3–82.5) 86.0 (75.3–96.0) 84.2 (74.0–92.0)
1. CART*+L. chagasi-ELISA 92.0 (86.0–96.0) 85.5 (75.0–93.0) 94.0 (90.2–97.4) 92.4 (86.5–96.3)
2. CART*+L. chagasi-ELISA 90.1 (81.0–96.0) 89.5 (75.2–97.0) 95.2 (91.4–99.0) 94.1 (86.0–98.4)
1. CART*+IFAT 92.5 (87.0–96.3) 71.0 (59.0–81.3) 94.0 (90.2–97.1) 86.0 (79.2–91.2)
2. CART*+IFAT 97.2 (92.2–100) 76.3 (60.0–89.0) 95.0 (89.0–100) 88.5 (79.2–95.0)
1. CART*+rK39-ELISA 98.0 (93.5–99.5) 88.4 (78.4–95.0) 97.2 (95.0–100) 94.2 (89.0–97.5)
2. CART*+rK39-ELISA 96.0 (88.1–99.1) 89.5 (75.2–97.1) 93.4 (87.0–100) 94.4 (86.4–98.5)
1. CART*+DAT 90.2 (84.0–95.0) 97.1 (90.0–100) 98.0 (96.1–99.5) 98.4 (94.2–100)
2. CART*+DAT 91.5 (82.5–97.0) 92.1 (79.0–98.3) 94.0 (87.3–100) 96.0 (88.0–99.1)
1. CART*+rK39 rapid test 94.0 (88.5–97.4) 98.5 (92.2–100) 99.0 (98.0–100) 99.2 (96.0–100)
2. CART*+rK39 rapid test 90.1 (81.0–96.0) 97.4 (86.2–100) 97.3 (95.0–100) 98.5 (92.0–100)
1 Test sample; 2 Validation sample.
*The CART model was composed by variables: Splenomegaly, leukopenia, cough, age and weight loss.
doi:10.1371/journal.pntd.0001542.t004
Figure 2. Example, based in models developed using logistic regression, on how a chart could be used.
doi:10.1371/journal.pntd.0001542.g002
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might impair the use of such models in many endemic areas where
a complete blood count is difficult to be performed. Unfortunately,
a model without leucopenia did not performed well in our sample.
Therefore, the development of simpler models with good
predictive performance in settings where blood counts are not
readily available is a challenge that should be explored in other
studies.
The scoring system derived from logistic regression and the
classification scheme based on CART models are simple and
based on the clinical-laboratory findings that are easily available in
most clinical settings. The model composed of clinical-laboratory
variables and the rK39 rapid test developed using both logistic
regression and the model CART showed the best performance
and it could be used in health services. This assessment tool could
support a physician’s decision but should not preclude his
assistance.
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